admin
America’s defenders of common sense are finally being heard. On Newsmax’s American Agenda, Dr. Deborah Birx and Melissa Francis rightly celebrated President Trump’s push to hold big pharmaceutical companies to most-favored-nation pricing, saying it puts American families in a stronger position to afford lifesaving medicines. For once the political class is being challenged and the administration is acting like it answers to working Americans, not to lobbyists or foreign price freeloaders.
This is not empty rhetoric — the administration has secured voluntary commitments from a string of major drugmakers to bring U.S. prices closer to the lowest prices paid in other developed nations, a practical step toward relief for seniors and families crushed by runaway costs. Those deals have continued to grow, with multiple companies signing on in recent months as the White House presses its advantage. Conservatives should celebrate concrete results, not endless committee hearings.
The logic is simple and patriotic: Americans should not subsidize the rest of the world’s drug bills while paying the highest prices on earth. President Trump’s executive actions and directives established the most-favored-nation framework to force a reckoning with decades of price gouging and waste, and to give taxpayers and Medicare the negotiating leverage they deserve. This is an American-first policy that treats medicine as a public priority, not a cash cow for multinational corporations.
Of course the left and their media allies are demanding secrecy-busting and outrage theater, but some of their complaints reveal more about sour partisan motives than about policy substance — critics point to unclear details while ignoring the urgent relief this delivers to patients now paying too much. If Democrats truly cared about lowering costs they would back transparency that leads to results instead of reflexively attacking a Republican president who is delivering outcomes. The public wants lower prices; the political class wants to protect the status quo.
Now is the time for Congress to stop posturing and put these agreements into law so families can count on fair prices for years to come. Patriots should rally behind leaders who defend American consumers and national medical security, not the pharmaceutical cartels that have profited for far too long. We owe Dr. Birx’s clear-eyed realism and outlets like Newsmax for telling the truth: this is a fight for the working people of this country, and conservatives should be proud to lead it.
